Noninvasive Submental Fat Compartment Treatment

Ava T Shamban, Ava T Shamban

Abstract

Background: KYBELLA, ATX-101, is an injectable form of sodium deoxycholic acid. It is currently the only Food and Drug Administration-approved injectable drug for the reduction of submental fat.

Objectives: A literature review and discussion of the treatment of submental fat.

Results: KYBELLA is a well-tolerated alternative for the treatment of submental fat.

Conclusions: KYBELLA is a safe and efficacious, first in class, injectable drug for the reduction of submental fat.

Conflict of interest statement

The author has no financial interest to declare in relation to the content of this article. The Article Processing Charge for this proceeding was paid for by Allergan plc, as part of an unrestricted educational grant to support the entire Cosmetic Boot Camp 2016 Supplement. Allergan plc had no involvement in the production, selection, or review of this proceeding supplement.

Figures

Fig. 1.
Fig. 1.
Site results of 4 consecutive treatments consisting of 4 mL of KYBELLA once every 30 days. Before treatment (A) and after treatment (B). Photograph is used with patient consent.
Fig. 2.
Fig. 2.
Site results of 6 KYBELLA treatments, 4 mL treatments spaced 30 days apart. Before treatment (A) and after treatment (B). Photograph is used with patient consent.
Fig. 3.
Fig. 3.
Landmarks for injections with KYBELLA. Reprinted with permission from Allergan plc.
Fig. 4.
Fig. 4.
Postplatysmal fat. Reprinted with permission from Allergan plc.
Fig. 5.
Fig. 5.
Anterior view of the preplatysmal fat. Reprinted with permission from Allergan plc.
Fig. 6.
Fig. 6.
Treatment area. Reprinted with permission from Allergan plc.

References

    1. Jones DH, Carruthers J, Joseph JH, et al. REFINE-1, a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction. Dermatol Surg. 2016;42:38–49.
    1. Duncan D, Rotunda AM. Injectable therapies for localized fat loss: state of the art, clinics in plastic surgery. Clin Plast Surg. 2011;38:489–501.
    1. Beer K, Donofrio L, Gross TM, et al. Clinically meaningful reduction in submental fat during and after treatment with ATX-101 in the US/CAN phase 3 trials, REFINE-1, and REFINE-2. Presented at 73rd Annual Meeting of the American Academy of Dermatology; March 20–24, 2015; San Francisco, CA.
    1. Coleman SR, Grover R. The anatomy of the aging face: volume loss and changes in 3-dimensional topography. Aesthet Surg J. 2006;26(1S):S4–S9.
    1. Ascher B, Hoffmann K, Walker P, et al. Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study. J Eur Acad Dermatol Venereol. 2014;28:1707–1715.
    1. Rzany B, Griffiths T, Walker P, et al. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study. Br J Dermatol. 2014;170:445–453.
    1. Hoffmann K, Rubin MG, Goodman G, et al. Reductions in submental fat achieved with ATX-101 (deoxycholic acid) are maintained over time. Presented at 13th Aesthetic & Anti-Aging Medicine World Congress; March 26–28, 2015; Monte Carlo, Monaco.
    1. Wollina U, Goldman A. ATX-101 for reduction of submental fat. Expert Opin Pharmacother. 2015;16:755–762.
    1. Kythera Biopharmaceuticals, Inc.: KYBELLA [Package Insert] Agoura Hills, CA: Kythera Biopharmaceuticals, Inc.; 2015. Available at: . Accessed March 15, 2016.
    1. Saedi N, Rotunda AM, Dover JS. Injectable fat-reducing therapies: fat reduction. In: Orringer JS, Murad A, Dover JS, editors. Body Shaping, Skin Fat and Cellulite: Procedures in Cosmetic Dermatology Series. Vol. 91 2014.
    1. Walker P, Fellmann J, Lizzul PF. A phase I safety and pharmacokinetic study of ATX-101: injectable, synthetic deoxycholic acid for submental contouring. J Drugs Dermatol. 2015;14:279–287.
    1. Schlessinger J, Weiss SR, Jewell M, et al. Perceptions and practices in submental fat treatment: a survey of physicians and patients. Skinmed. 2013;11:27–31.
    1. Farrior E, Eisler L, Wright HV. Techniques for rejuvenation of the neck platysma. Facial Plast Surg Clin North Am. 2014;22:243–252.
    1. Rohrich RJ, Rios JL, Smith PD, et al. Neck rejuvenation revisited. Plast Reconstr Surg. 2006;118:1251–1263.
    1. Batra AP, Mahajan A, Gupta K. Marginal mandibular branch of the facial nerve: an anatomical study. Indian J Plast Surg. 2010;43:60–64.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe